Literature DB >> 18202186

Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.

Caterina Bianco1, Luigi Strizzi, Mario Mancino, Kazuhide Watanabe, Monica Gonzales, Shin Hamada, Ahmed Raafat, Lawson Sahlah, Cindy Chang, Federica Sotgia, Nicola Normanno, Michael Lisanti, David S Salomon.   

Abstract

Human and mouse Cripto-1 (CR-1/Cr-1) proteins play an important role in mammary gland development and tumorigenesis. In this study, we examined the relationship between Cripto-1 and caveolin-1 (Cav-1), a membrane protein that acts as a tumor suppressor in the mammary gland. Cripto-1 was found to interact with Cav-1 in COS7 cells and mammary epithelial cells. Using EpH4 mouse mammary epithelial cells expressing Cr-1 (EpH4 Cr-1) or Cr-1 and Cav-1 (EpH4 Cr-1/Cav-1), we demonstrate that Cav-1 expression markedly reduced the ability of Cr-1 to enhance migration, invasion, and formation of branching structures in EpH4 Cr-1/Cav-1 cells as compared to EpH4 Cr-1 cells. Furthermore, coexpression of Cav-1 together with Cr-1 in EpH4 Cr-1/Cav-1 cells inhibited Cr-1-mediated activation of c-src and mitogen-activated protein kinase signaling pathways. Conversely, primary mammary epithelial cells isolated from Cav-1 null(-/-)/mouse mammary tumor virus-CR-1 transgenic animals showed enhanced motility and activation of mitogen-activated protein kinase and c-src as compared to Cav-1(+/-)/CR-1 mammary cells. Finally, mammary tumors derived from mouse mammary tumor virus-CR-1 mice showed a dramatic reduction of Cav-1 expression as compared to mammary tissue from normal FVB/N mice, suggesting that in vivo Cav-1 is down-regulated during the process of CR-1-mediated mammary tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202186      PMCID: PMC2312365          DOI: 10.2353/ajpath.2008.070696

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  73 in total

1.  Transforming growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells.

Authors:  Eric A Schwartz; Eve Reaven; James N Topper; Philip S Tsao
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

Review 2.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

3.  Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells.

Authors:  S Kannan; M De Santis; M Lohmeyer; D J Riese; G H Smith; N Hynes; M Seno; R Brandt; C Bianco; G Persico; N Kenney; N Normanno; I Martinez-Lacaci; F Ciardiello; D F Stern; W J Gullick; D S Salomon
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

4.  Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells.

Authors:  A D Ebert; C Wechselberger; S Frank; B Wallace-Jones; M Seno; I Martinez-Lacaci; C Bianco; M De Santis; H K Weitzel; D S Salomon
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

5.  Left-right asymmetric expression of lefty2 and nodal is induced by a signaling pathway that includes the transcription factor FAST2.

Authors:  Y Saijoh; H Adachi; R Sakuma; C Y Yeo; K Yashiro; M Watanabe; H Hashiguchi; K Mochida; S Ohishi; M Kawabata; K Miyazono; M Whitman; H Hamada
Journal:  Mol Cell       Date:  2000-01       Impact factor: 17.970

6.  Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells.

Authors:  S W Lee; C L Reimer; P Oh; D B Campbell; J E Schnitzer
Journal:  Oncogene       Date:  1998-03       Impact factor: 9.867

7.  Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line.

Authors:  F Ciardiello; R Dono; N Kim; M G Persico; D S Salomon
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

8.  Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor.

Authors:  Kazuhide Watanabe; Shin Hamada; Caterina Bianco; Mario Mancino; Tadahiro Nagaoka; Monica Gonzales; Veronique Bailly; Luigi Strizzi; David S Salomon
Journal:  J Biol Chem       Date:  2007-10-09       Impact factor: 5.157

9.  Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice.

Authors:  Jean Philippe Gratton; Michelle I Lin; Jun Yu; Erik D Weiss; Zao Li Jiang; Todd A Fairchild; Yasuko Iwakiri; Roberto Groszmann; Kevin P Claffey; Yung Chi Cheng; William C Sessa
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

10.  Identification and biological characterization of an epidermal growth factor-related protein: cripto-1.

Authors:  R Brandt; N Normanno; W J Gullick; J H Lin; R Harkins; D Schneider; B W Jones; F Ciardiello; M G Persico; F Armenante
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

View more
  9 in total

Review 1.  Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.

Authors:  Peter C Gray; Wylie Vale
Journal:  FEBS Lett       Date:  2012-02-01       Impact factor: 4.124

Review 2.  Targeting the embryonic gene Cripto-1 in cancer and beyond.

Authors:  Caterina Bianco; David S Salomon
Journal:  Expert Opin Ther Pat       Date:  2010-11-13       Impact factor: 6.674

3.  Cripto-1 modulates macrophage cytokine secretion and phagocytic activity via NF-κB signaling.

Authors:  Dong-mei Zhang; Yong-Li Bao; Chun-Lei Yu; Yi-meng Wang; Zhen-Bo Song
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 4.  The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.

Authors:  Malgorzata Klauzinska; Nadia P Castro; Maria Cristina Rangel; Benjamin T Spike; Peter C Gray; Daniel Bertolette; Frank Cuttitta; David Salomon
Journal:  Semin Cancer Biol       Date:  2014-08-19       Impact factor: 15.707

5.  Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.

Authors:  Tadahiro Nagaoka; Hideaki Karasawa; Thomas Turbyville; Maria-Cristina Rangel; Nadia P Castro; Monica Gonzales; Alyson Baker; Masaharu Seno; Stephen Lockett; Yoshimi E Greer; Jeffrey S Rubin; David S Salomon; Caterina Bianco
Journal:  Cell Signal       Date:  2012-09-27       Impact factor: 4.315

Review 6.  From embryonic development to human diseases: The functional role of caveolae/caveolin.

Authors:  Jihee Sohn; Rachel M Brick; Rocky S Tuan
Journal:  Birth Defects Res C Embryo Today       Date:  2016-03-17

7.  Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells.

Authors:  Caterina Bianco; Nadia P Castro; Christina Baraty; Kelly Rollman; Natalie Held; Maria Cristina Rangel; Hideaki Karasawa; Monica Gonzales; Luigi Strizzi; David S Salomon
Journal:  J Cell Physiol       Date:  2013-06       Impact factor: 6.384

8.  Effect of cavtratin, a caveolin-1 scaffolding domain peptide, on oligodendroglial signaling cascades.

Authors:  Matthias Schmitz; Inga Zerr; Hans H Althaus
Journal:  Cell Mol Neurobiol       Date:  2011-04-27       Impact factor: 5.046

9.  CRIPTO/GRP78 signaling maintains fetal and adult mammary stem cells ex vivo.

Authors:  Benjamin T Spike; Jonathan A Kelber; Evan Booker; Madhuri Kalathur; Rose Rodewald; Julia Lipianskaya; Justin La; Marielle He; Tracy Wright; Richard Klemke; Geoffrey M Wahl; Peter C Gray
Journal:  Stem Cell Reports       Date:  2014-04-03       Impact factor: 7.765

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.